Navigation Links
Rancho BioSciences will present the tranSMART open source platform at TM Forum’s Digital Disruption 2013, Oct 28-31, San Jose
Date:10/22/2013

San Diego, California (PRWEB) October 22, 2013

Rancho BioSciences, the global scientific data consulting company announced today that they will be representing the open source platform tranSMART, originally from Johnson & Johnson, at TM Forum’s Digital Disruption 2013 conference and expo. This conference takes place at the San Jose convention center, October 28-31. Rancho will be located in the Disruption Zone adjacent to the Innovation Theater. Representatives from Rancho will be showing how tranSMART can be used to store and analyze OMICs and clinical data in order to support personalized medicine. They will be showing real examples from their work with the Accelerated Cure Project and Orion Bionetworks who have funded the collection of the large multiple sclerosis data set that is now ready for analysis. Curated clinical information analyzed alongside with genomic, proteomic, and biomarker data helps participating researchers make novel hypotheses about disease mechanisms, forecast disease progression, and identify novel targets for disease treatment. The types and amount of new data now available require sophisticated technology solutions all working synergistically – for example, scalable and flexible cloud computing, adaptable but dependable security modules, solutions for big data, and capabilities for data integration.

Digital Disruption brings together key players and innovators in the digital ecosystem to focus on the challenges and opportunities being tackled today including: Innovating faster, and leveraging disruptive innovations, exploiting new service revenue streams, especially enterprise cloud-based services and increasing flexibility and business agility by applying advanced business processes and IT.

“We will show people at the meeting how tranSMART can be used as an analysis platform to understand disease mechanisms once high quality curated data has been uploaded into the system”, said Julie Bryant, founder and CEO of Rancho BioSciences. “We have a hosted version of tranSMART that will be made available for testing after the meeting for those that are interested that include curated data sets from the public domain. Our customers are using tranSMART to develop diagnostics for diseases, build disease progression models as well as supporting successful clinical trials.”

"Orion Bionetworks is a leading user of the TranSmart platform and plans to use it when launching its next generation program, Orion 2.0., for which we are currently seeking sponsors", Dr. Magali Haas, Founder and CEO, Orion Bionetworks.

About Rancho BioSciences
Rancho BioSciences is a fee for service data curation company leveraging open source tools and public domain data. Our customers include Pharma, Institutes and Academics.

We have a team of experienced PhD and MD scientists around the world that deliver high quality work based on their expertise and domain knowledge in biology, diseases and clinical data. Rancho BioSciences is flexible and cost effective providing on site and off site curators.

Rancho BioSciences also has expertise in databases and hosts or installs tranSMART for their customers.

Our goal is to help the life science community build better tools and take advantage of a wealth of scientific data by supporting and developing open source platforms.

For more information about Rancho BioSciences, please visit us online at ranchobiosciences.com.

Read the full story at http://www.prweb.com/releases/2013/10/prweb11244653.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Rancho BioSciences Partners with OmicSoft for Manual Data Curation
2. Rancho BioSciences Launches Rancho tranSMART Hosted for Clinical and Genomic Data Storage and Analysis
3. Microvi and Aquatech Break Ground on Large Demonstration System at Aerojet Site in Rancho Cordova, CA
4. Jeeven BioSciences, Inc. Announces the Release of Its Neuro-XTM Serum-Free and Xeno-Free Tissue Culture Media
5. Castle Biosciences Launches Tissue Repository for Eye Cancer Patients
6. Biotechs Leading the Healthcare Sector - Alliqua, Pacific Biosciences, Oncothyreon, Keryx, Organovo
7. Proove Biosciences Continues Its Research Leadership in the Genetics of Pain Medicine at The American Academy of Pain Management’s 24th Annual Meeting
8. MD Biosciences Publishes the Characterization of a Porcine Model of Post-operative Or Incisional Pain in the European Journal of Pain
9. Regado Biosciences, Inc. to Present at Aegis Capital Vegas Healthcare Conference
10. SAGE Labs, Inc. Licenses CRISPR/Cas9 genome engineering technology from Caribou Biosciences, Inc.
11. Sangamo BioSciences Announces Closing Of $74.2 Million Public Offering Of Common Stock And Exercise Of Over-Allotment Option
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 24, 2017 , ... Chef Jodi Abel has returned from her three-week ... cities, she gained a number of delicious recipes and new techniques to share with ... Africa’s Western Cape province. It is internationally renowned for its incredible wine farms, ...
(Date:2/24/2017)... -- China Cord Blood Corporation (NYSE: CO ... cord blood collection, laboratory testing, hematopoietic stem cell processing ... financial results for the third quarter and first nine ... Third Quarter of Fiscal 2017 Highlights ... 2017 increased by 18.6% to RMB200.9 million ($28.9 million). ...
(Date:2/23/2017)... YORK , Feb. 23, 2017 ... digital health company, and Digital Noema Telehealth ... remote patient monitoring, announce they are partnering to ... DN Telehealth maximizes collaboration compatibility for its ... beyond a physical clinical setting to include fully ...
(Date:2/23/2017)... it seems everyone has a chance to express their personalities. ... and dynamic community unlike any other. The businesses that succeed ... With their newest salon in Dunwoody ... that tradition with a unique, fresh approach to head lice ... newest of 13 nationwide locations, each of them well-situated in ...
Breaking Biology Technology:
(Date:2/16/2017)... , Feb. 16, 2017  Genos, a ... announced that it has received Laboratory Accreditation from ... Accreditation is presented to laboratories that meet stringent ... demonstrate scientifically rigorous processes. "Genos is ... in laboratory practices. We,re honored to be receiving ...
(Date:2/10/2017)... -- Research and Markets has announced the ... Scientific and Commercial Aspects" to their offering. ... Biomarkers play ... therapy for selection of treatment as well for monitoring the ... disease in modern medicine. Biochip/microarray technologies and next generation sequencing ...
(Date:2/8/2017)... 7, 2017 Report Highlights ... The global synthetic-biology market reached ... by 2021, growing at a compound annual growth rate (CAGR) ... of the global markets for synthetic biology. - Analyses of ... and projections of compound annual growth rates (CAGRs) through 2021. ...
Breaking Biology News(10 mins):